Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Kahn Brothers Group, latest 13F

GSK

In Kahn Brothers Group's portfolio · Kahn Brothers Group

Ticker GSK

Still in the portfolio as of Q3 2026. Every quarter it shows up in a Kahn Brothers Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2026 Reduce 28% 113,552 0.9% $48.17 $5.5M
Q2 2026 Reduce 2% 158,438 1.3% $52.42 $8.3M
Q1 2026 Reduce 10% 160,982 1.6% $55.19 $8.9M
Q4 2025 Reduce 31% 178,696 1.6% $49.04 $8.8M
Q3 2025 Reduce 60% 260,837 2.1% $43.16 $11.3M
Q2 2025 Reduce 20% 659,872 5.1% $38.40 $25.3M
Q1 2025 Reduce 7% 822,227 6.4% $38.74 $31.9M
Q4 2024 Reduce 16% 884,708 6.5% $33.82 $29.9M
Q3 2024 Reduce 15% 1,058,832 7.5% $40.88 $43.3M
Q2 2024 Reduce 1% 1,241,261 8.0% $38.50 $47.8M
Q1 2024 No change 1,253,644 8.0% $42.87 $53.7M
Q4 2023 Reduce 2% 1,259,482 7.4% $37.06 $46.7M
Q3 2023 Add 1% 1,282,289 7.3% $36.25 $46.5M
Q2 2023 Reduce 1% 1,263,458 6.6% $35.64 $45.0M
Q1 2023 Add 4% 1,277,476 6.5% $35.58 $45.5M
Q4 2022 Reduce 6% 1,226,906 5.7% $35.14 $43.1M
Q3 2022 Reduce 9% 1,304,939 6.0% $29,429.87 $38.40B
Q2 2022 No change 1,431,160 8.4% $43,529.70 $62.30B
Q1 2022 Reduce 1% 1,426,664 7.9% $43,560.21 $62.15B
Q4 2021 Add 6% 1,438,569 8.7% $44,100.00 $63.44B
Q3 2021 Add 4% 1,353,358 7.3% $38,210.00 $51.71B
Q2 2021 Add 2% 1,297,109 7.4% $39,820.00 $51.65B
Q1 2021 Reduce 1% 1,265,770 7.0% $35,690.00 $45.18B
Q4 2020 Reduce 9% 1,281,924 8.2% $36,800.00 $47.17B
Q3 2020 Reduce 7% 1,406,689 10.0% $37,640.00 $52.95B
Q2 2020 Reduce 2% 1,517,918 10.5% $40,978.11 $62.20B
Q1 2020 Reduce 3% 1,543,618 10.7% $37,890.00 $58.49B
Q4 2019 Reduce 2% 1,587,628 9.0% $46,990.63 $74.60B
Q3 2019 Add 1% 1,620,599 8.7% $42,680.00 $69.17B
Q2 2019 Add 26% 1,605,014 8.0% $40,020.00 $64.23B
Q1 2019 Add 1% 1,276,550 8.3% $41,790.00 $53.35B
Q4 2018 Add 2% 1,260,940 8.7% $38,210.00 $48.18B
Q3 2018 No change 1,241,516 7.7% $40,170.00 $49.87B
Q2 2018 No change 1,236,592 7.9% $40,310.00 $49.85B
Q1 2018 Add 8% 1,230,642 7.7% $39,070.00 $48.08B
Q4 2017 Add 12% 1,139,163 6.3% $35,470.00 $40.41B
Q3 2017 Reduce 3% 1,021,135 6.3% $40,600.00 $41.46B
Q2 2017 No change 1,055,085 6.9% $43,120.00 $45.50B
Q1 2017 Add 26% 1,050,995 7.6% $42,160.00 $44.31B
Q4 2016 Add 32% 833,315 5.4% $38,510.00 $32.09B
Q3 2016 Add 66% 632,040 5.0% $43,288.22 $27.36B
Q2 2016 Add 188% 380,335 3.2% $43,340.00 $16.48B
Q1 2016 Add 56% 131,950 1.0% $40,550.00 $5.35B
Q4 2015 Add 47% 84,600 0.6% $40,350.00 $3.41B
Q3 2015 Reduce 1% 57,500 0.4% $38,450.00 $2.21B
Q2 2015 No change 58,200 0.4% $41,650.00 $2.42B
Q1 2015 Add 14% 58,200 0.5% $46,150.00 $2.69B
Q4 2014 No change 51,000 0.4% $42,740.00 $2.18B
Q3 2014 Buy 51,000 0.4% $45,970.00 $2.34B

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.